96 Tests PN: A111110

32 Tests PN: A111110T


45x Ab-conjugated beads (S4P2 - human G-SCF Ab-bead).

  • 96 Tests PN: A111110A. One vial containing 100 µL of anti-human G-CSF conjugated to AimPlex Bead S4P2.

  • 32 Tests PN: A111110TA. One vial containing 35 µL of anti-human G-CSF conjugated to AimPlex Bead S4P2.

25x Biotin-detection Ab (human G-CSF Biotin-dAb).

  • 96 Tests PN: A111110B. One vial containing 100 µL of biotinylated anti-human G-CSF.

  • 32 Tests PN: A111110TB. One vial containing 35 µL of biotinylated anti-human G-CSF.

Lyophilized Standard Mix-Human Group 2 Panel A, 10-Plex.

  • 96 & 32 Tests PN: HG2009A. One vial containing lyophilized recombinant human G-CSF, GM-CSF, IFNα2, IL-1α, IL-3, IL-5, IL-7, IL-11, IL-12p40, and IL-13. Note: If multiple analyte kits on the above target list are ordered as a panel, only one vial of standard mix is supplied for those analyte kits. 

Application: Optimal antibody pair and antigen standard for assaying human G-CSF/CSF-3.  Can be multiplexed with other analytes in Human Group 2.  To be used in conjunction with the AimPlex NR Basic Kit (96 Tests PN: P100001, 32 Tests PN: P100001T) and a diluent kit. Refer to the AimPlex Multiplex Immunoassay User Manual and kit inserts for the assay procedure.

Storage:  2-8 C in the dark.

Important: Sodium azide forms explosive compounds with heavy metals. These products contain <0.05% (w/w) azide which with repeated contact with lead and copper commonly found in plumbing drains may result in the buildup of shock sensitive compounds. Dispose in accordance with regulations from your institute.

For Research Use Only.  Not for use in diagnostic procedures.

Assay Specifications:

  • Sample types: Cell culture supernatant, serum, plasma, bodily fluid and tissue/cell lysate

  • Sensitivity (LOD): < 5 pg/mL

  • Quantitation range:

  • LLOQ: < 10 pg/mL

  • ULOQ: > 5,000 pg/mL

  • Standard dose recovery: 70-130%

  • Intra-assay CV: < 10%

  • Inter-assay CV: < 20%

  • Cross-reactivity of analytes in Human Group 2: Negligible

  • Sample volume: 15 µL/test


Granulocyte-colony stimulating factor (Accession P09919) is a member of colony-stimulating factor cytokine family produced by many different cells. G-CSF can be produced by macrophages as well as fibroblasts and mesothelial and endothelial cells. As a glycoprotein, it encourages the production of granulocytes and stem cells from bone marrow. G-CSF exists in two forms: a 174 amino acid form and a 177 amino acid form. G-CSF 174 is more abundant and active. G-CSF mediates neutrophil distribution and certain functions. Recombinant G-CSF is purported to accelerate recovery for patients with certain cancers and treatments as it may increase the number of hematopoietic progenitor cells.


  1. Demetri GD, Grififn JD. Granuloycte Colony-Stimulating Factor and Its Receptor. Blood. 1991; 78(11): 2791-2808.

  2. Deotare U, Al-Dawsari G, Couban S, Lipton JH. G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept. Bone Marrow Transplant. 2015; 50(9): 1150-6. Doi: 10.1038/bmt.2015.80.

  3. Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, et al. Molecular cloning and expression of cDNA for human granulocyte colongy-stimulating factor. Nature. 1986; 319: 415-418. Doi: 10.1038.319415a0.